Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters










Publication year range
1.
JMIR Serious Games ; 11: e42025, 2023 Oct 16.
Article in English | MEDLINE | ID: mdl-37843885

ABSTRACT

BACKGROUND: Needle phobia, which affects 19% of children aged 4 to 6 years, prevents many children from receiving necessary or preventive medical treatments. Digital interventions have been made to target needle phobia but currently rely on distraction rather than evidence-based exposure. OBJECTIVE: We designed and evaluated a serious exposure-based mobile game called Dr. Zoo to reduce the fear of needles in children aged 3 to 6 years, where players administered shots to cartoon animals. METHODS: We conducted a mixed methods study with 30 parents (mean age 35.87, SD 4.39 years) and their 36 children (mean age 4.44, SD 1.11 years) who played the game for 5 days leading to a scheduled appointment that included an injection (eg, influenza vaccination). After the study, parents completed exit surveys and participated in semistructured interviews to evaluate ease of use, acceptability, and preliminary effectiveness of the game and to provide insights on their experience with the game to inform future developments. Interview transcripts were analyzed by 3 independent coders following an open coding process and subsequently coded and discussed to reach consensus. RESULTS: Parents rated their child's difficulty in completing the game as very low on average (scale 1-5; mean 1.76, SD 0.82) and were highly likely to recommend Dr. Zoo to other parents (scale 1-5; mean 4.41, SD 0.87), suggesting Dr. Zoo's strong ease of use and high acceptability. In the exit survey, parents rated their child's fear as significantly lower after participating in the study (scale 1-5; mean 3.09, SD 1.17) compared with that before participating (scale 1-5; mean 4.37, SD 0.81; z score=-4.638; P<.001). Furthermore, 74% (26/35) of the parents reported that the game had a positive impact on their child's fear or perception of needles (only 2 parents reported a negative impact). Qualitative analysis of the interview transcripts revealed potentially important features of the game in this positive impact, such as the game's interactive design, as observed in 69% (24/35) of our participants. CONCLUSIONS: The results suggest that an evidence-based serious mobile game can be an easy-to-use, acceptable, and potentially effective intervention for changing young children's fear and perceptions of needles. Leveraging digital interventions may be a potential solution to needle anxiety as a public health concern.

2.
J Med Imaging Radiat Oncol ; 58(5): 612-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25091019

ABSTRACT

INTRODUCTION: Cancer-related mortality rates are higher in rural areas compared with urban regions. Whether there are corresponding geographical variations in radiotherapy utilisation rates (RURs) is the subject of this study. METHODS: RURs for the regional centre of Geelong and rural areas of the Barwon South Western Region were calculated using a population-based database (2009). RESULTS: Lower RURs were observed for rural patients compared with the Geelong region for prostate cancer (15.7% vs 25.8%, P = 0.02), rectal cancer (32.8% vs 44.7%, P = 0.11), lymphoma (9.4% vs 26.2%, P = 0.05), and all cancers overall (25.6% vs 28.9%, P = 0.06). This lower rate was significant in men (rural, 19.9%; Geelong, 28.3%; P = 0.00) but not in women (rural, 33.6%; Geelong, 29.7%; P = 0.88). Time from diagnosis to radiotherapy was not significantly different for patients from the two regions. Tumour staging within the rural and Geelong regions was not significantly different for the major tumour streams of rectal, prostate and lung cancer (P = 0.61, P = 0.79, P = 0.43, respectively). A higher proportion of tumours were unstaged or unstageable in the rural region for lung (44% vs 18%, P < 0.01) and prostate (73% vs 57%, P < 0.01) cancer. CONCLUSION: Lower RURs were observed in our rural region. Differences found within tumour streams and in men suggest a complexity of relationships that will require further study.


Subject(s)
Health Services Accessibility/statistics & numerical data , Neoplasms/epidemiology , Neoplasms/radiotherapy , Radiotherapy, Conformal/statistics & numerical data , Rural Population/statistics & numerical data , Time-to-Treatment/statistics & numerical data , Utilization Review , Adult , Age Distribution , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prevalence , Sex Distribution , Victoria/epidemiology
3.
Nurs Stand ; 20(10): 26-7, 2005.
Article in English | MEDLINE | ID: mdl-16318074

ABSTRACT

From her early days in cancer nursing, Kathy Redmond was determined to make life better for patients. Her efforts have helped ensure that the views of cancer patients are now higher up the European agenda.


Subject(s)
Job Satisfaction , Oncology Nursing , Female , Humans , Patient Advocacy
7.
Nurs Stand ; 19(7): 12-3, 2004.
Article in English | MEDLINE | ID: mdl-15551911
11.
J Neurol ; 251(12): 1515-21, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15645353

ABSTRACT

The standard therapy for episodes of severe acute inflammatory demyelinating disease of the central nervous system is high dose intravenous corticosteroids. A small proportion of patients fail to improve with this regime and their prognosis can become grave. A recent sham controlled double blind crossover trial in this group of patients demonstrated a significant benefit from plasma exchange. We report six patients with severe acute steroid-insensitive inflammatory demyelinating disease of the central nervous system treated with plasma exchange. We observed a clear improvement in five of these six patients. Whilst complications of plasma exchange occurred these did not outweigh the benefits. Our study supports the use of plasma exchange in severe acute steroid-insensitive inflammatory disease of the central nervous system.


Subject(s)
Demyelinating Autoimmune Diseases, CNS/therapy , Plasma Exchange , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Drug Resistance , Female , Humans , Male , Plasma Exchange/adverse effects , Treatment Outcome
16.
SELECTION OF CITATIONS
SEARCH DETAIL